• Policy
• Reimb of Enhertu, Ilaris pass DREC review…deemed adequate
• by Lee, Tak-Sun Feb 5, 2024 05:53am

• Policy
• Price of drugs listed in 2002-2006 may be adjusted next year
• by Lee, Tak-Sun Feb 2, 2024 12:28pm

• Policy
• Referencing lowest A8 price will result in a supply crisis
• by Nho, Byung Chul Jan 29, 2024 06:05am

• Policy
• Remote GMP inspections not recognized from April
• by Lee, Hye-Kyung Jan 29, 2024 06:05am

• Policy
• Lilly’s UC drug Omvoh is soon to be approved in KOR
• by Lee, Hye-Kyung Jan 26, 2024 05:51am

• Policy
• P2T for LG Chem’s obesity drug LB54640 approved in Korea
• by Lee, Hye-Kyung Jan 26, 2024 05:51am

• Policy
• MOHW “Drug pricing for listed drugs is set to be reduced"
• by Lee, Jeong-Hwan Jan 26, 2024 05:50am

• Policy
• Chong Kun Dang cuts price of its Lucen BS by half
• by Lee, Tak-Sun Jan 25, 2024 05:50am

• Policy
• Handok-Sanofi launches hypertension combo drug Aprovasc
• by Lee, Tak-Sun Jan 24, 2024 05:45am

• Policy
• New drug Zavicefta Inj, and more completed drug pricing nego
• by Lee, Tak-Sun Jan 23, 2024 06:02am